GeneCopoeia, Inc.

GeneCopoeia, a provider of turn-key technologies, tools and services. GeneCopoeia sells ready-for-use 16,000 human full length ORF clones in 40 expression vectors, which can be used in gene function studies and protein productions individually and in large scale. Also offers 5000 recombinant proteins, antibodies, customer cloning and protein production services.

Activity:

- Contract Manufacturing
- Contract Research
- Informatics
- Licensing & Business Development
- Manufacturing
- Market Research & Marketing
- Research & Development
- Sales & Distribution

Product / Technology type(s) covered:

- Bio
- Enzymes
- FP (finished products)
- Proteins
- Reagents
- Technology

Therapeutic targets:

Markets Covered

a. HeadQuarter: United States of America

b. Continent(s) active: North America , Europe , Asia , Australia/New-Zealand , Central/South America , Near/Middle East

c. Countries active: USA Japan Germay UK

Corporate data:

Number of Employees: 60

Turnover:

Amount:	Year:	Currency:
2 millions	2004	US Dollar

Year founded: 1999